LumiraDx Ltd

LMDX

NASDAQ. Currency in USD

1.06 -0.10 ( -8.62% )

Real time prices: September 26

Market Cap.
331.89M
Beta (5Y monthly)
-
Price/Earnings
-
EPS (TTM)
-1.06
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
220,639
1y Target Est.
14.94
Day's Range
1.02
-
1.16
52 Week's Range
1.02
-
11.09

Historical Summary

Performance
EPS growth
Share Buybacks

About LumiraDx Ltd

Sector
Healthcare
Industry
Diagnostics & Research
Website
https://www.lumiradx.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
207.46M
Employees
1513
Address
3 More London Riverside, London, United Kingdom, SE1 2AQ
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.

Latest news

LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance
LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance

Testing Times Report reflects expert opinion that “Supporting more widespread use of rapid diagnostic technology...
By GlobeNewswire Inc. - 4 days ago

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday...
By Benzinga - 1 week ago

Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket
Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket

Gainers Micro Focus International plc (NYSE: MFGP) shares rose 93.6% to $6.06 in pre-market trading...
By Benzinga - 4 weeks ago

Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 206% to close at $48.01 on Friday...
By Benzinga - 5 weeks ago

Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session
Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following...
By Benzinga - 5 weeks ago

General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday

GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the...
By Benzinga - 5 weeks ago

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on...
By Benzinga - 5 weeks ago

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Mind Medicine (MindMed)...
By Benzinga - 5 weeks ago